Drug and Alcohol Dependence
Volume 88 , Pages S61-S71 , May 2007

Measurement-based care for refractory depression: A clinical decision support model for clinical research and practice

  • Madhukar H. Trivedi

      Affiliations

    • Corresponding Author InformationCorresponding author at: Mood Disorders Program, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9119, USA. Tel.: +1 214 648 0181; fax: +1 214 648 0167.
    • ,
  • Ella J. Daly

Received 29 March 2006 ,Revised 29 December 2006 ,Accepted 12 January 2007.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Text Revision. fourth ed.. Washington, DC: American Psychiatric Press; 2000;
  2. Bakish D. New standard of depression treatment: remission and full recovery. J. Clin. Psychiatry. 2001;62(Suppl. (26)):5–9
  3. Bauer MS. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv. Rev. Psychiatry. 2002;10:138–153
  4. Biggs MM, Shores-Wilson K, Rush AJ, Carmody TJ, Trivedi MH, Crismon ML, et al. A comparison of alternative assessments of depressive symptom severity: a pilot study. Psychiatry Res. 2000;96:269–279
  5. Buff KR, Kaufman L, Thomas JP. Handbook of Perception and Human Performance. Cognitive Processes and Performance. vol. 11. New York, NY: John Wiley; 1986;
  6. Cabana MD, Clark N. Challenges in evaluating methods to improve physician practice. J. Pediatr. 2003;143:413–414
  7. Chen RS, Rosenheck R. Using a computerized patient database to evaluate guideline adherence and measure patterns of care for major depression. J. Behav. Health Serv. Res. 2001;28:466–474
  8. Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, et al. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study. Addict. Behav. 2000;25:307–310
  9. Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, et al. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J. Clin. Psychiatry. 1999;60:142–156
  10. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700–705
  11. Deering MJ. Developing the health information infrastructure in the United States. Stud. Health Technol. Inform. 2002;80:121–128
  12. Depression Guideline Panel, 1993a. Clinical Practice Guideline, Number 5: Depression in Primary Care. Detection and Diagnosis, vol. 1. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville, MD.
  13. Depression Guideline Panel, 1993b. Clinical Practice Guideline, Number 5: Depression in Primary Care. Treatment of Major Depression, vol. 2. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville, MD.
  14. Deyo RA, Carter WB. Strategies for improving and expanding the application of health status measures in clinical settings. A researcher-developer viewpoint. Med. Care. 1992;30:MS176–MS186
  15. Evans CE, Haynes RB, Birkett NJ, Gilbert JR, Taylor DW, Sackett DL, et al. Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. JAMA. 1986;255:501–504
  16. Ford DE. Managing patients with depression: is primary care up to the challenge?. J. Gen. Intern. Med. 2000;15:344–345
  17. Fortney JC, Booth BM, Curran GM. Do patients with alcohol dependence use more services? A comparative analysis with other chronic disorders. Alcohol. Clin. Exp. Res. 1999;23:127–133
  18. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223–1238
  19. Gemson DH, Ashford AR, Dickey LL, Raymore SH, Roberts JW, Ehrlich MH, et al. Putting prevention into practice. Impact of a multifaceted physician education program on preventive services in the inner city. Arch. Intern. Med. 1995;155:2210–2216
  20. Gorton TA, Cranford CO, Golden WE, Walls RC, Pawelak JE. Primary care physicians’ response to dissemination of practice guidelines. Arch. Fam. Med. 1995;4:135–142
  21. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, et al. The effect of depression on return to drinking: a prospective study. Arch. Gen. Psychiatry. 1998;55:259–265
  22. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  23. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  24. Hauenstein EJ. Depression in adolescence. J. Obstet. Gynecol. Neonatal Nurs. 2003;32:239–248
  25. Hayward RS. Clinical practice guidelines on trial. Can. Med. Assoc. J. 1997;156:1725–1727
  26. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol. 1988;49:219–224
  27. Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280:1339–1346
  28. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch. Gen. Psychiatry. 1998;55:694–700
  29. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995;273:1026–1031
  30. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch. Gen. Psychiatry. 2004;61:1042–1049
  31. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765
  32. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch. Gen. Psychiatry. 1992;49:809–816
  33. Kelly JF, McKellar JD, Moos R. Major depression in patients with substance use disorders: relationship to 12-step self-help involvement and substance use outcomes. Addiction. 2003;98:499–508
  34. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105
  35. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry. 1985;142:1259–1264
  36. Lin EH, Katon WJ, Simon GE, Von KM, Bush TM, Rutter CM, et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough?. Med. Care. 1997;35:831–842
  37. Lin EHB, Von Korff M, Katon W, Bush T, Simon GE, Walker E, et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Med. Care. 1995;33:67–74
  38. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N. Engl. J. Med. 1989;321:1306–1311
  39. Mallin R, Slott K, Tumblin M, Hunter M. Detection of substance use disorders in patients presenting with depression. Subst. Abus. 2002;23:115–120
  40. Margolis CZ, Warshawsky SS, Goldman L, Dagan O, Wirtschafter D, Pliskin JS. Computerized algorithms and pediatricians’ management of common problems in a community clinic. Acad. Med. 1992;67:282–284
  41. Mark TL. The costs of treating persons with depression and alcoholism compared with depression alone. Psychiatr. Serv. 2003;54:1095–1097
  42. Murray C, Lopez A. Global Health Statistics: A Compendium of Incidence, Prevalence and Mortality Estimates for over 2000 Conditions. Cambridge: Harvard School of Public Health; 1996;
  43. Ouimette PC, Gima K, Moos RH, Finney JW. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes. Alcohol Clin. Exp. Res. 1999;23:552–557
  44. Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol. Psychiatry. 2004;56:785–792
  45. Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A. Double-blind clinical trial of sertraline treatment for alcohol dependence. J. Clin. Psychopharmacol. 2001;21:143–153
  46. Rousseau N, McColl E, Newton J, Grimshaw J, Eccles M. Practice based, longitudinal, qualitative interview study of computerised evidence based guidelines in primary care. BMJ. 2003;326:314
  47. Roy A. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biol. Psychiatry. 1998;44:633–637
  48. Rubenstein LV, Mittman BS, Yano EM, Mulrow CD. From understanding health care provider behavior to improving health care: the QUERI framework for quality improvement. Quality Enhancement Research Initiative. Med. Care. 2000;38:I129–I141
  49. Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, et al. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol. Psychiatry. 2006;59:493–501Epub 2005 September 30
  50. Rush AJ, Carmody TJ, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int. J. Methods Psychiatr. Res. 2000;9:45–59
  51. Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, et al. Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J. Clin. Psychiatry. 2003;64:357–369
  52. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol. Med. 1996;26:477–486
  53. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, et al. Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–1853
  54. Rush AJ, Trivedi M, Carmody TJ, Biggs MM, Shores-Wilson K, Ibrahim H, et al. One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies. Biol. Psychiatry. 2004;56:46–53
  55. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry. 2003;54:573–583Erratum p. 585
  56. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. 2006;354:1231–1242
  57. Schulberg HC, Katon W, Simon GE, Rush AJ. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch. Gen. Psychiatry. 1998;55:1121–1127
  58. Sim I, Gorman P, Greenes RA, Haynes RB, Kaplan B, Lehmann H, et al. Clinical decision support systems for the practice of evidence-based medicine. J. Am. Med. Inform. Assoc. 2001;8:527–534
  59. Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen. Hosp. Psychiatry. 1993;15:399–408
  60. Smith WR. Evidence for the effectiveness of techniques to change physician behavior. Chest. 2000;118:8S–17S
  61. Tierney WM. Improving clinical decisions and outcomes with information: a review. Int. J. Med. Inform. 2001;62:1–9
  62. Trivedi MH, Claassen CA, Grannemann BD, Kashner TM, Carmody TJ, Daly E, et al. Assessing physicians’ use of treatment algorithms: Project IMPACTS Study Design and Rationale. Contemp. Clin. Trials. 2007;28:192–212
  63. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, et al. Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. 2006;354:1243–1252
  64. Trivedi MH, Kern JK, Baker SM, Altshuler KZ. Computerizing medication algorithms and decision support systems for major psychiatric disorders. J. Psychiatr. Pract. 2000;6:237–246
  65. Trivedi MH, Kern JK, Grannemann BD, Altshuler KZ, Sunderajan P. A computerized clinical decision support system as a means of implementing depression guidelines. Psychiatr. Serv. 2004;55:879–885
  66. Trivedi MH, Kern JK, Marcee A, Grannemann B, Kleiber B, Bettinger T, et al. Development and implementation of computerized clinical guidelines: barriers and solutions. Methods Inf. Med. 2002;41:435–442
  67. Trivedi MH, Kern JK, Voegtle TM, Baker SM, Altshuler KZ. Computerized medication algorithms in behavioral health care. In:  Dewan NA,  Lorenzi N,  Riley R,  Bhattacharya SR editor. Behavioral Health Care Informatics. Springer-Verlag New York Inc., in cooperation with Springer-Verlag GmbH & Co., KG Berlin Heidelberg; 2001;p. 53–63
  68. Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch. Gen. Psychiatry. 2004;61:669–680
  69. Trivedi, M.H., Rush, A.J., Gaynes, B.N., Stewart, J.W., Wisniewski, S.R., Warden, D., Ritz, L., Luther, J., Stegman, D., DeVeaugh-Geiss, J., Howland, R.H. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology, in press.
  70. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol. Med. 2004;34:73–82
  71. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry. 2006;163:28–40
  72. Trivedi MH, Rush AJ, Wisniewski SR, Warden D, McKinney W, Downing M, et al. Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J. Clin. Psychiatry. 2006;67:185–195
  73. Unützer J, Katon W, Callahan CM, Williams JW, Hunkeler E, Harpole L, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836–2845
  74. Ware JE, Kosinski M, Keller SD. A 12-item Short-Form Health Survey. Construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34:220–233
  75. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA. Self-rated global measure of the frequency, intensity, and burden of side effects. J. Psychiatr. Pract. 2006;12:71–79
  76. World Health Organization, 2001. World Health Report 2001. Mental Health: New Understanding, New Hope. World Health Organization, Geneva, Switzerland.

PII: S0376-8716(07)00024-5

doi: 10.1016/j.drugalcdep.2007.01.007

Drug and Alcohol Dependence
Volume 88 , Pages S61-S71 , May 2007

Article Tools

* Image Usage & Resolution